Biblio
βKlotho is identified as a target for theranostics in non-small cell lung cancer. Theranostics. 2019;9(25):7474-7489.
. Immunomodulatory Biomaterials and Their Application in Therapies for Chronic Inflammation-Related Diseases. Acta Biomater. 2021.
. Exosomes from human adipose-derived mesenchymal stem cells attenuate localized scleroderma fibrosis by the let-7a-5p/TGF-βR1/Smad axis. J Dermatol Sci. 2023.
. Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics. 2023;13(13):4391.
.